New Drug Approved for Deadly Lung Condition, First in Over a Decade

(MedPage Today) — The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
Primary support for the preferential…

Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/117841

Author :

Publish date : 2025-10-07 20:52:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

New Drug Approved for Deadly Lung Condition, First in Over a Decade

RFK Jr. ‘Endangering the Health of the Nation,’ Former Surgeons General Say

Canakinumab Better Than Anakinra in Treating VEXAS Syndrome

Related Posts

Amid Shutdown Fight, Healthcare Is One of the Most Intractable Issues in Congress

Canakinumab Better Than Anakinra in Treating VEXAS Syndrome

RFK Jr. ‘Endangering the Health of the Nation,’ Former Surgeons General Say

Medicaid Work Requirements Will Devastate People With Invisible Disabilities

Lifestyle May Preserve Bone Health in Seniors With Obesity

HRT May Get Revised Label; Costco to Sell No-Insurance Ozempic; CGM Without Diabetes

Amid Shutdown Fight, Healthcare Is One of the Most Intractable Issues in Congress

Canakinumab Better Than Anakinra in Treating VEXAS Syndrome

New Drug Approved for Deadly Lung Condition, First in Over a Decade

RFK Jr. ‘Endangering the Health of the Nation,’ Former Surgeons General Say

Medicaid Work Requirements Will Devastate People With Invisible Disabilities

Lifestyle May Preserve Bone Health in Seniors With Obesity

HRT May Get Revised Label; Costco to Sell No-Insurance Ozempic; CGM Without Diabetes

The Man Who Escaped Alzheimer’s; Shingles and Dementia; ALS Risk After Brain Injury

Categories

Archives